These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21180650)

  • 41. Clinical development of intramuscular electroporation: providing a "boost" for DNA vaccines.
    Khan AS; Broderick KE; Sardesai NY
    Methods Mol Biol; 2014; 1121():279-89. PubMed ID: 24510832
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthetic vehicles for DNA vaccination.
    van den Berg JH; Nuijen B; Schumacher TN; Haanen JB; Storm G; Beijnen JH; Hennink WE
    J Drug Target; 2010 Jan; 18(1):1-14. PubMed ID: 19814658
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bringing DNA vaccines closer to commercial use.
    Carvalho JA; Prazeres DM; Monteiro GA
    IDrugs; 2009 Oct; 12(10):642-7. PubMed ID: 19790015
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Applicator and electrode design for in vivo DNA delivery by electroporation.
    Rabussay D
    Methods Mol Biol; 2008; 423():35-59. PubMed ID: 18370189
    [TBL] [Abstract][Full Text] [Related]  

  • 45. DNA vaccines for cancer.
    Boyd D; Hung CF; Wu TC
    IDrugs; 2003 Dec; 6(12):1155-64. PubMed ID: 14666426
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An update on the state of the art of DNA vaccines.
    Ulmer JB
    Curr Opin Drug Discov Devel; 2001 Mar; 4(2):192-7. PubMed ID: 11378958
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-cytolytic antigen clearance in DNA-vaccinated mice with electroporation.
    Peng JL; Zhao YG; Mai JH; Pang WK; Guo W; Chen GM; Mo GY; Rao GR; Xu YH
    Acta Pharmacol Sin; 2007 Jul; 28(7):1024-30. PubMed ID: 17588339
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Electroporation at low voltages enables DNA vaccine to provide protection against a lethal H5N1 avian influenza virus challenge in mice.
    Zhou Y; Fang F; Chen J; Wang H; Chang H; Yang Z; Chen Z
    Intervirology; 2008; 51(4):241-6. PubMed ID: 18812697
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DNA vaccination strategies for anti-tumour effective gene therapy protocols.
    Signori E; Iurescia S; Massi E; Fioretti D; Chiarella P; De Robertis M; Rinaldi M; Tonon G; Fazio VM
    Cancer Immunol Immunother; 2010 Oct; 59(10):1583-91. PubMed ID: 20390416
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Strategies for DNA vaccine delivery.
    Alpar HO; Papanicolaou I; Bramwell VW
    Expert Opin Drug Deliv; 2005 Sep; 2(5):829-42. PubMed ID: 16296781
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effective gene transfer to solid tumors using different nonviral gene delivery techniques: electroporation, liposomes, and integrin-targeted vector.
    Cemazar M; Sersa G; Wilson J; Tozer GM; Hart SL; Grosel A; Dachs GU
    Cancer Gene Ther; 2002 Apr; 9(4):399-406. PubMed ID: 11960291
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Delivery of DNA vaccines using electroporation.
    Babiuk S; van Drunen Littel-van den Hurk S; Babiuk LA
    Methods Mol Med; 2006; 127():73-82. PubMed ID: 16988447
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DNA vaccines against cancer come of age.
    Stevenson FK; Ottensmeier CH; Rice J
    Curr Opin Immunol; 2010 Apr; 22(2):264-70. PubMed ID: 20172703
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DNA vaccines for biodefence.
    Garmory HS; Perkins SD; Phillpotts RJ; Titball RW
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1343-61. PubMed ID: 15935877
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo electroporation of skeletal muscles increases the efficacy of Japanese encephalitis virus DNA vaccine.
    Wu CJ; Lee SC; Huang HW; Tao MH
    Vaccine; 2004 Mar; 22(11-12):1457-64. PubMed ID: 15063569
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin.
    McCoy JR; Mendoza JM; Spik KW; Badger C; Gomez AF; Schmaljohn CS; Sardesai NY; Broderick KE
    Hum Vaccin Immunother; 2015; 11(3):746-54. PubMed ID: 25839221
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression.
    Bins AD; Jorritsma A; Wolkers MC; Hung CF; Wu TC; Schumacher TN; Haanen JB
    Nat Med; 2005 Aug; 11(8):899-904. PubMed ID: 15965482
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adipose tissue: a new target for electroporation-enhanced DNA vaccines.
    Fisher PD; Brambila CJ; McCoy JR; Kiosses WB; Mendoza JM; Oh J; Yung BS; Schultheis K; Smith TRF; Broderick KE
    Gene Ther; 2017 Dec; 24(12):757-767. PubMed ID: 29106403
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is electroporation decisive for the efficacy of DNA vaccine against house dust mite allergy?
    Pulsawat P; Jacquet A
    Expert Rev Vaccines; 2013 Sep; 12(9):977-9. PubMed ID: 24053390
    [No Abstract]   [Full Text] [Related]  

  • 60. Electroporation-based DNA immunisation: translation to the clinic.
    Luxembourg A; Evans CF; Hannaman D
    Expert Opin Biol Ther; 2007 Nov; 7(11):1647-64. PubMed ID: 17961089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.